Development And Characterization Of Niosomal Transdermal Formulation Loaded Lecarnidipine Hydrochloride
Abstract
Introduction and Background: For several medications, matrix-based transdermal formulations have been created. Derma as a delivery system for medicinal agents has recently seen a renaissance as a viable option for both local and systemic drug delivery. The current work set out to design and evaluate transdermal medication delivery patches based on niosomes as its aim and objectives.
Material and Methods: An improved formulation of LCP nanoparticles with a polydispersity index and a particle size of 225 nm was achieved using solvent evaporation. Using solvent casting techniques, LCP patches were prepared by dispersing nanoparticles in a variety of polymers and sodium alginate concentrations. The patches were then optimized using a central composite design. In-vitro drug release studies and ex-vivo skin permeation studies were conducted.
Results: A member of the BCS class of drugs, lecarnidipine hydrochloride has a poor solubility but, because to its niosomes, is able to pass the blood-brain barrier and enter the bloodstream. The transdermal patch now contains lecarnidipine niosomes, which were successfully integrated utilizing HPMC E5 and HPMC 15cps. A lecarnidipine niosomal patch with a 10 mg dosage released its contents more quickly.
References
2. Shefrin S, Sreelaxmi CS, Vijayan V, Nair SC. Anti-epileptic drug loaded niosomal transdermal patch for enhanced skin permeation. Int J App Pharm. 2019 Mar 7;11(2):31-43.
3. Auda SH, Fathalla D, Fetih G, El-Badry M, Shakeel F. Niosomes as transdermal drug delivery system for celecoxib: in vitro and in vivo studies. Polymer Bulletin. 2016 May;73:1229-45.
4. Sen P, Khulbe P, Ahire ED, Gupta M, Chauhan N, Keservani RK. Skin and soft tissue diseases and their treatment in society. Community Acquired Infection. 2023 May 30;10.
5. Padmaja B, Rani SS. Formulation development and characterization of Lecarnidipine hydrochloride niosomal transdermal patches. Journal of Drug Delivery and Therapeutics. 2023 Aug 15;13(8):100-9.
6. Verma M, Ahire ED, Jaiswal A, Prajapati M, Keservani RK, Sable RR. Innovative treatment methods for skin fungal infections in community. Community Acquired Infection. 2024 Sep 12;11.
7. Khulbe, P., Singh, D.M., Aman, A., Ahire, E.D. and Keservani, R.K., The emergence of nanocarriers in the management of diseases and disorders. Community Acquired Infection, 2023:10.
8. Bharti. AD., Keservani R. K., Sharma. AK., Kesharwani Rajesh, K., & Mohammed GH., Formulation and in vitro characterization of metoprolol tartrate loaded chitosan microspheres. Ars Pharmaceutica, 2012:(53-3):13-18.
9. Keservani RK, & Sharma, AK, Nanoemulsions: Formulation Insights, Applications, and Recent Advances. Nanodispersions for Drug Delivery, 2018: 71-96.
10. Keservani RK, Sharma, AK, & Ramteke S, Novel vesicular approach for topical delivery of baclofen via niosomes. Lat Am J Pharm, 2010: 29: 1364-1370.
11. Keservani, Raj K. and Gautam, Surya Prakash., Formulation and evaluation of baclofen liposome vesicles using lecithin, ARS Pharmaceutica, 2020:61 (3): 175-180.
12. Keservani, Raj K. and Gautam, Surya Prakash., Skeletal muscle relaxant activity of different formulation of span 60 niosome, ARS Pharmaceutica, 2022:63 (1): 32-44.
13. Behera, J., Keservani, R. K., Yadav, A., Tripathi, M., & Chadoker, A., Methoxsalen loaded chitosan coated microemulsion for effective treatment of psoriasis. International Journal of Drug Delivery, 2010: 2: 159-167.
14. Keservani R K, Praveena R, Pawar S V, Devi R, Tiwari S W, Patel V K, Guru P V., Uddin N., Insilico Efficacy of Quercetin As A Therapeutic Potential For Colorectal Cancer, Afr.J.Bio.Sc. 2024: 6(Si2): 3322-3329.
15. Komu, L.T., Dharmalingam, S., Kumar, S., Keservani, R. K., Joshi, N., Rajesh, K.S., Sakarkar, S.N., Vippamakula, S., Mehta, F.F., Formulation Development and Evaluation of Thermo-Responsive BIOGELS: Nose to Brain Approach, JCHR, 2023:13(3): 839-844.
16. Nataraja, B. T., Dharmalingam, S., Keservani, R. K, Gupta, A. K, Pulipati, S, Bhor R. J., Singh, A.K., Singh, S.K., Boddeda, B., Silver Nanoparticle Formulation Development and Evaluation: In-Vitro Anti-Microbial Evidences, JCHR, 2023:13(3):1389-1396.
17. Jaiswal, M., Gupta, A.A., Singh, AK., Keservani, R.K., Kachave R.N., Amrutkar S.V., Simultaneous Estimation of Olmesartan Medoxomil and Hydrochlorothiazide in Bulk Drug and its Tablet Formulation by RP-HPLC, Eur. Chem. Bull., 2023:12 (11): 74 – 86.
18. Gautam, S. P., Keservani, R. K., Gautam, T., Gupta, A. K., & Kumar Sharma, A., An alternative approach for acetylation of amine terminated polyamidoamine (PAMAM) dendrimer. Ars Pharm. 2015: 56(3): 155-159.
19. Khambete, H., Keservani, R. K., Kesharwani, R. K., Jain, N. P., & Jain, C. P., Emerging trends of nanobiomaterials in hard tissue engineering. Nanobiomaterials in Hard Tissue Engineering, 2016: 63-101.
20. Keservani, R. K., Bandopadhyay, S., Bandyopadhyay, N., & Sharma, A. K., Design and fabrication of transdermal/skin drug-delivery system. In Drug Delivery Systems, Academic Press, 2020:131-178.
21. Sharma, VK., Koka A., Yadav J., Sharma AK., & Keservani, R. K., Self-micro emulsifying drug delivery systems: A strategy to improve oral bioavailability, Ars Pharm. 2016; 57(3): 97-109.
22. Padmaja B, Rani SS. Formulation development and characterization of Lecarnidipine hydrochloride niosomal transdermal patches. Journal of Drug Delivery and Therapeutics. 2023 Aug 15;13(8):100-9.
23. Kokande AM, Surana KR, Ahire ED, Keservani RK, Mahajan SK. Vitamins as Nutraceuticals for Skin Care. InPreventive and Therapeutic Role of Vitamins as Nutraceuticals 2024 Apr 23 (pp. 235-252). Apple Academic Press.
24. Kar K, Sudheer P. Formulation and evaluation of niosomal drug delivery system of ketoprofen. RGUHS J Pharm Sci. 2015;5(4):173-80.
25. Keservani RK, Bandopadhyay S, Bandyopadhyay N, Sharma AK. Design and fabrication of transdermal/skin drug-delivery system. InDrug Delivery Systems 2020 Jan 1 (pp. 131-178). Academic Press.
26. Bathe R, Kapoor R. Transdermal drug delivery system: formulation, development and evaluation-An overview. Drug Deliv. 2015;6:7-12.
27. Muzzalupo R, Tavano L. Niosomal drug delivery for transdermal targeting: recent advances. Research and reports in transdermal drug delivery. 2015 Jul 29:23-33.
28. Gujarathi NA, Bakliwal AA, Rane BR, Pathan V, Keservani RK. Regulatory aspects of drug development for dermal products. InTopical and Transdermal Drug Delivery Systems 2023 Feb 6 (pp. 287-310). Apple Academic Press.
29. Yasam VR, Jakki SL, Natarajan J, Venkatachalam S, Kuppusamy G, Sood S, Jain K. A novel vesicular transdermal delivery of nifedipine–preparation, characterization and in vitro/in-vivo evaluation. Drug delivery. 2016 Feb 12;23(2):619-30.
30. Gujarathi NA, Patil TS, Rane BR, Babu A, Keservani RK. Micro-and Nano-Systems in Transdermal Drug Delivery. InTopical and Transdermal Drug Delivery Systems 2023 Feb 6 (pp. 41-78). Apple Academic Press.
31. Afreen U, Fahelelbom KM, Shah SN, Ashames A, Almas U, Khan SA, Yameen MA, Nisar N, Asad MH, Murtaza G. Formulation and evaluation of niosomes-based chlorpheniramine gel for the treatment of mild to moderate skin allergy. Journal of Experimental Nanoscience. 2022 Dec 31;17(1):467-95.
32. Keservani RK, Bandopadhyay S, Bandyopadhyay N, Sharma AK. Design and fabrication of transdermal/skin drug-delivery system. InDrug Delivery Systems 2020 Jan 1 (pp. 131-178). Academic Press.
33. Raj BS, Samraj PI. Formulation evaluation and optimization of proniosome based transdermal patches of ketorolac. Pharmaceutical and Biosciences Journal. 2016 Feb 6:01-12.
34. El-Ridy MS, Yehia SA, Mohsen AM, El-Awdan SA, Darwish AB. Formulation of niosomal gel for enhanced transdermal lornoxicam delivery: in-vitro and in-vivo evaluation. Current Drug Delivery. 2018 Jan 1;15(1):122-33.
35. Zidan AS, Hosny KM, Ahmed OA, Fahmy UA. Assessment of simvastatin niosomes for pediatric transdermal drug delivery. Drug delivery. 2016 Jun 12;23(5):1536-49.
36. Thakur R, Anwer MK, Shams MS, Ali A, Khar RK, Shakeel F, Taha EI. Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation. Journal of drug targeting. 2009 Jul 1;17(6):442-9.
37. Ibrahim MM, Nair AB, Aldhubiab BE, Shehata TM. Hydrogels and their combination with liposomes, niosomes, or transfersomes for dermal and transdermal drug delivery. InLiposomes 2017 Oct 25 (pp. 155-186). London, UK: IntechOpen.
38. Hamishehkar H, Rahimpour Y, Kouhsoltani M. Niosomes as a propitious carrier for topical drug delivery. Expert opinion on drug delivery. 2013 Feb 1;10(2):261-72.
39. Kumar GP, Rao PR. Ultra deformable niosomes for improved transdermal drug delivery: The future scenario. Asian Journal of Pharmaceutical Sciences. 2012 Feb 1;7(1).
40. Monika B, Amit R, Sanjib B, Alisha B, Mihir P, Dhanushram T. Transdermal drug delivery system with formulation and evaluation aspects: overview. Research Journal of Pharmacy and Technology. 2012;5(9):1168-76.
41. Dumitriu Buzia O, Păduraru AM, Stefan CS, Dinu M, Cocoș DI, Nwabudike LC, Tatu AL. Strategies for Improving Transdermal Administration: New Approaches to Controlled Drug Release. Pharmaceutics. 2023 Apr 7;15(4):1183.
42. Meer S, Tahir MA, Abbasi MS. Formulation based technology advancements in transdermal drug delivery system. Asian Journal of Research in Dermatological Science. 2020 Aug 1;3(3):20-33.